Also, these results are in line with the survey study that found cardiologists who introduced pre- and peri-cardiac interventions estimation of L-FABP into patient care were 2.9 times more likely to correctly identify their patients' risk for AKI and were more than twice as likely to treat AKI [40]. The gene discussed is FABP1; the disease is acute kidney injury.